These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23340121)

  • 1. Systems biology approaches to evaluate arsenic toxicity and carcinogenicity: an overview.
    Bhattacharjee P; Chatterjee D; Singh KK; Giri AK
    Int J Hyg Environ Health; 2013 Aug; 216(5):574-86. PubMed ID: 23340121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenicosis: review of recent advances.
    Pimparkar BD; Bhave A
    J Assoc Physicians India; 2010 Oct; 58():617-24, 629. PubMed ID: 21510113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms?
    Simeonova PP; Luster MI
    J Environ Pathol Toxicol Oncol; 2000; 19(3):281-6. PubMed ID: 10983894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicogenomic approaches for understanding molecular mechanisms of heavy metal mutagenicity and carcinogenicity.
    Koedrith P; Kim H; Weon JI; Seo YR
    Int J Hyg Environ Health; 2013 Aug; 216(5):587-98. PubMed ID: 23540489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicogenomics of arsenic: classical ideas and recent advances.
    Ghosh P; Banerjee M; Giri AK; Ray K
    Mutat Res; 2008; 659(3):293-301. PubMed ID: 18638567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic cancer risk posed to human health from tilapia consumption in Taiwan.
    Liao CM; Shen HH; Lin TL; Chen SC; Chen CL; Hsu LI; Chen CJ
    Ecotoxicol Environ Saf; 2008 May; 70(1):27-37. PubMed ID: 18068227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of NALP2 polymorphism with arsenic induced skin lesions and other health effects.
    Bhattacharjee P; Das N; Chatterjee D; Banerjee A; Das JK; Basu S; Banerjee S; Majumder P; Goswami P; Giri AK
    Mutat Res; 2013 Jul; 755(1):1-5. PubMed ID: 23644288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological and experimental applications to occupational cancer prevention.
    Vainio H; Hemminki K
    J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic-induced toxicity and carcinogenicity: a two-wave cross-sectional study in arsenicosis individuals in West Bengal, India.
    Paul S; Das N; Bhattacharjee P; Banerjee M; Das JK; Sarma N; Sarkar A; Bandyopadhyay AK; Sau TJ; Basu S; Banerjee S; Majumder P; Giri AK
    J Expo Sci Environ Epidemiol; 2013 Mar; 23(2):156-62. PubMed ID: 22990472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects.
    Schuhmacher-Wolz U; Dieter HH; Klein D; Schneider K
    Crit Rev Toxicol; 2009; 39(4):271-98. PubMed ID: 19235533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of occupational exposure to asbestos, silicon and arsenic on pulmonary disorders: Understanding the genetic-epigenetic interplay and future prospects.
    Bhattacharjee P; Paul S; Bhattacharjee P
    Environ Res; 2016 May; 147():425-34. PubMed ID: 26966890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologically based pharmacokinetic modeling of arsenic in the mouse.
    Gentry PR; Covington TR; Mann S; Shipp AM; Yager JW; Clewell HJ
    J Toxicol Environ Health A; 2004 Jan; 67(1):43-71. PubMed ID: 14668111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?
    Snow ET; Sykora P; Durham TR; Klein CB
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):557-64. PubMed ID: 15996700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.
    Clewell HJ; Thomas RS; Gentry PR; Crump KS; Kenyon EM; El-Masri HA; Yager JW
    Toxicol Appl Pharmacol; 2007 Aug; 222(3):388-98. PubMed ID: 17499324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epimutagenesis: A prospective mechanism to remediate arsenic-induced toxicity.
    Paul S; Giri AK
    Environ Int; 2015 Aug; 81():8-17. PubMed ID: 25898228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2-mediated redox signaling in arsenic carcinogenesis: a review.
    Sinha D; Biswas J; Bishayee A
    Arch Toxicol; 2013 Feb; 87(2):383-96. PubMed ID: 22914984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment.
    Kitchin KT; Conolly R
    Chem Res Toxicol; 2010 Feb; 23(2):327-35. PubMed ID: 20035570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of genomic instability in arsenic-induced carcinogenicity. A review.
    Bhattacharjee P; Banerjee M; Giri AK
    Environ Int; 2013 Mar; 53():29-40. PubMed ID: 23314041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.